The United States and Ivory Coast have formalised a landmark $487 million bilateral health agreement aimed at boosting the West African nation’s capacity to prevent, detect and respond to major diseases including HIV/AIDS, malaria and tuberculosis. The deal, signed in Abidjan, is part of a broader U.S. strategy to shift global health cooperation toward sustainable, partner‑led systems while supporting domestic resource mobilisation for health priorities.
Under the multi‑year pact, U.S. support will be integrated into Ivory Coast’s national health systems, with funding directed at strengthening disease surveillance, improving epidemic preparedness, and expanding essential health services nationwide. Officials said the agreement represents a strategic shift from traditional aid models toward long‑term investment and shared ownership of public health initiatives.
Ivorian health authorities welcomed the partnership, noting it will significantly improve health outcomes for vulnerable populations and bolster the state’s ability to manage health crises more effectively. U.S. diplomatic representatives emphasised that the collaboration is built on mutual accountability and long‑term cooperation, marking one of several bilateral agreements the U.S. has pursued across Africa to stabilise and strengthen public health sectors.
